J.P. Morgan: Johnson & Johnson's Drug Segment May Beat Q2 Street Views
July 10, 2014 at 16:31 PM EDT
Johnson & Johnson's (NYSE: JNJ) pharmaceuticals products may drive second-quarter results to just above Street views when it ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.